argenx to Buy Forte Biosciences for $2.2 Billion to Add Autoimmune Drug Candidate
argenx has agreed to acquire Forte Biosciences for approximately $2.2 billion in cash, moving to secure an experimental autoimmune-disease therapy that could be
argenx has agreed to acquire Forte Biosciences for approximately $2.2 billion in cash, moving to secure an experimental autoimmune-disease therapy that could be